UnitedHealth Group Operating Income Over Time
| UNH Stock | USD 293.18 0.00 0.00% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out UnitedHealth Group Performance and UnitedHealth Group Correlation. UnitedHealth | Build AI portfolio with UnitedHealth Stock |
Is there potential for Health Care Providers & Services market expansion? Will UnitedHealth introduce new products? Factors like these will boost the valuation of UnitedHealth Group. If investors know UnitedHealth will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about UnitedHealth Group listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (1.00) | Dividend Share 8.73 | Earnings Share 19.2 | Revenue Per Share | Quarterly Revenue Growth 0.123 |
Understanding UnitedHealth Group requires distinguishing between market price and book value, where the latter reflects UnitedHealth's accounting equity. The concept of intrinsic value - what UnitedHealth Group's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push UnitedHealth Group's price substantially above or below its fundamental value.
Please note, there is a significant difference between UnitedHealth Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if UnitedHealth Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, UnitedHealth Group's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Cross Equities Operating Income Analysis
Compare UnitedHealth Group and related stocks such as Novartis AG ADR, Abbott Laboratories, and AstraZeneca PLC Operating Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NVS | 5 B | 10.8 B | 11.5 B | 11 B | 11.1 B | 9 B | 8.3 B | 8.7 B | 8.4 B | 9.1 B | 10.2 B | 10.1 B | 7.9 B | 9.8 B | 14.5 B | 17.1 B | 9.6 B |
| ABT | 737.1 M | 6.8 B | 2 B | 2.1 B | 2.9 B | 2.9 B | 3.2 B | 2 B | 3.8 B | 4.6 B | 5.3 B | 9.2 B | 8.4 B | 6.4 B | 6.8 B | 8 B | 4.1 B |
| AZN | 1.2 B | 12.8 B | 8.1 B | 3.7 B | 2.1 B | 4.1 B | 4.9 B | 3.7 B | 3.4 B | 2.9 B | 5.2 B | 1.1 B | 3.8 B | 8.2 B | 10 B | 13.7 B | 14.4 B |
| CI | (854.9 M) | 1.9 B | 2.9 B | 32.4 B | 11.6 B | 12.4 B | 3.1 B | 3.9 B | 4.2 B | 8.1 B | 8.2 B | 7.9 B | 8.4 B | 8.5 B | 9.4 B | 9.1 B | 9.6 B |
| MRK | 839.8 M | 9 B | 9.9 B | 7.7 B | 6.7 B | 7.5 B | 5.5 B | 6.8 B | 8.9 B | 7.9 B | 5.5 B | 13.2 B | 18.3 B | 3 B | 20.2 B | 26.8 B | 28.1 B |
| NVO | 733.3 M | 22.4 B | 29.5 B | 31.5 B | 34.5 B | 49.4 B | 48.4 B | 49 B | 47.2 B | 52.5 B | 54.1 B | 58.6 B | 74.8 B | 102.6 B | 128.3 B | 129.8 B | 136.3 B |
| TMO | 4.9 M | 1.5 B | 1.6 B | 1.8 B | 2.3 B | 2.5 B | 2.9 B | 3.3 B | 3.9 B | 4.3 B | 7.9 B | 10.3 B | 8.5 B | 6.9 B | 7.7 B | 8.1 B | 8.5 B |
| CVS | 449 M | 6.3 B | 7.2 B | 8 B | 8.8 B | 9.5 B | 10.4 B | 9.5 B | 4 B | 12 B | 13.9 B | 13.3 B | 8 B | 13.7 B | 8.5 B | 10.4 B | 10.9 B |
| ELV | 11.1 B | 4.5 B | 4.4 B | 4.7 B | 5.1 B | 5.4 B | 5.4 B | 5 B | 5.8 B | 6.7 B | 7.7 B | 8.9 B | 8.5 B | 8.7 B | 8.9 B | 8.1 B | 6.8 B |
UnitedHealth Group and related stocks such as Novartis AG ADR, Abbott Laboratories, and AstraZeneca PLC Operating Income description
Operating Income is the amount of profit realized from UnitedHealth Group operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of UnitedHealth Group Incorporated is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| UnitedHealth Group Incorporated | UNH |
| Classification | Obamacare Repeal |
| Business Address | 1 Health Drive, |
| Exchange | New York Stock Exchange |
USD 293.18
Check out UnitedHealth Group Performance and UnitedHealth Group Correlation. You can also try the Stocks Directory module to find actively traded stocks across global markets.
UnitedHealth Group technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.